The National Dexamethasone shows promise treating severe COVID-19 patients

The National Dexamethasone shows promise treating severe COVID-19 patients

Researchers in the U.K. say dexamethasone, a widely available corticosteroid, reduced COVID-19 deaths by up to one-third in severely ill hospitalized patients.

  • 2020
  • 00:03:38
  • 13-14
  • Added on: 07/03/2020
Curio.ca users can access content from outside their institution. You must find your access code and then create an account.

Metadata

Subjects
COVID-19 (Disease) [LCSH] Coronavirus infections -- Treatment [LCSH] Glucocorticoids [LCSH] Science [LCSH] Medical sciences [LCSH]
Team
Christine Birak (Journalist), Andrew Chang (Host)
Closed captioning
Available
MARC Record
View Download

Can be found in

Categories